March 13, 2019
In this video, Dr. Streutker talks about the updated CAP protocols for esophageal and gastric cancers
Watch as Dr. Catherine Streutker talks about updates to the AJCC eighth edition CAP protocols to esophageal squamous cell carcinoma and adenocarcinoma, as well as gastric adenocarcinoma. She also reviews the principles of gastric GEJ Her2 testing, and other biomarkers and new therapies.
Catherine Streutker, MD, MSc, FRCPC, is the Director of the Surgical Pathology group at St. Michael’s Hospital in Toronto, Ontario, Canada. She graduated in 1989 with her BSc in Biochemistry, Co-op from the University of Waterloo in Waterloo, Ontario. In 1991, she earned a Master’s degree in Clinical Biochemistry at the University of Toronto (U of T). After graduating from medical school in 1994 at U of T, she entered the Anatomic Pathology Residency program and wrote the Royal College Exam in 1999. Dr. Streutker completed a two-year fellowship in Gastrointestinal Pathology at McMaster University in Hamilton, Ontario. In 2001, she joined the Department of Laboratory Medicine and Pathobiology at U of T and began as a Staff Pathologist at St. Michael’s Hospital.
Watch the video for the 2019 CAP education session about esophageal and gastric cancers
The Partnership, the Canadian Association of Pathologists (CAP-ACP), and Cancer Care Ontario (CCO) have organized this College of American Pathologists (CAP) education session.
In July 2009, the CAP-ACP endorsed the cancer protocols developed by CAP as the Canada-wide standard for all cancer-pathology reporting. To date, CAP protocols have been implemented in six Canadian provinces with the CAP-ACP’s support.
The protocols help pathologists to report effectively about diagnostic and prognostic findings, which are critical to patient care and the collection of collaborative stage data. The protocols were developed by multidisciplinary teams and are supported by CAP in both paper and electronic formats.